Publication | Closed Access
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.
141
Citations
16
References
1992
Year
A combination of CPT-11 and cisplatin seems to be effective against NSCLC with acceptable toxicities. The recommended dose for phase II studies is 60 mg/m2 of CPT-11 on days 1, 8, and 15, and 80 mg/m2 of cisplatin on day 1 every 4 weeks.
| Year | Citations | |
|---|---|---|
Page 1
Page 1